USPTO Examiner ALTER MORSCHAUSER ALYSSA MARGO - Art Unit 3792

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
17137141Closed Loop Control in Spinal Cord Stimulation Therapy with Non-detectable Neural ResponsesDecember 2020June 2023Allow2920YesNo
17127433HEAD CAP WITH CHANNEL IDENTIFICATIONDecember 2020December 2022Allow2420NoNo
17124340MICRO DEVICE OF NERVE SIGNAL RECORDING AND STIMULATING FOR DIAGNOSIS AND TREATMENT OF CHRONIC PAIN OR ALZHEIMER'S DISEASEDecember 2020July 2023Allow3120YesNo
17104543STIMULATION SYSTEMS AND RELATED USER INTERFACESNovember 2020March 2023Allow2710NoNo
17102848METHOD OF SEARCHING OPTIMAL ZONES FOR ELECTROPULSE THERAPY (VARIANTS)November 2020October 2022Allow2200YesNo
16951745Signaling Error Conditions in an Implantable Medical Device System Using Simple Charging Coil TelemetryNovember 2020November 2022Allow2410NoNo
17056345DEVICE FOR EXTRAVASAL OR EXTRANEURONAL FASTENING OF A MEDICAL IMPLANT IN THE MANNER OF A COMPRESSION SLEEVENovember 2020February 2023Allow2720NoNo
17099103SYSTEM TO DIAGNOSE AND MANAGE ORTHOSTATIC INTOLERANCENovember 2020September 2023Abandon3420YesNo
17098183NEUROMODULATION SYSTEMNovember 2020August 2023Allow3330YesNo
17054982R-R INTERVAL ANALYSIS FOR ECG WAVEFORMS TO ASSESS AUTONOMIC RESPONSE TO VAGUS NERVE STIMULATIONNovember 2020May 2022Allow1830YesNo
17086070NERVE ROOT AND DORSAL ROOT GANGLION STIMULATION FROM THE LATERAL EPIDURAL SPACEOctober 2020April 2022Allow1810NoNo
17082439Electrode assembly for nerve stimulationOctober 2020November 2022Allow2520YesNo
17050618NON-INVASIVE NERVE STIMULATION DEVICES, ELECTRODE ASSEMBLIES, AND METHODS OF USE THEREOFOctober 2020March 2021Allow500NoNo
17068011MULTI-THRESHOLD SENSING OF CARDIAC ELECTRICAL SIGNALS IN AN IMPLANTABLE MEDICAL DEVICEOctober 2020September 2022Allow2310YesNo
17061727MODULAR ELECTRICAL THERAPY DEVICEOctober 2020September 2022Allow2400NoNo
17034506Systems and Methods for the Automated Delivery of Photobiomodulation Therapy to a PatientSeptember 2020November 2022Abandon2610NoNo
17031493PULSED PASSIVE CHARGE RECOVERY CIRCUITRY FOR AN IMPLANTABLE MEDICAL DEVICESeptember 2020October 2022Allow2510NoNo
17008199NEUROSLEEVE FOR CLOSED LOOP EMG-FES BASED CONTROL OF PATHOLOGICAL TREMORSAugust 2020May 2023Allow3220NoNo
17002135NEUROSLEEVE FOR CLOSED LOOP EMG-FES BASED CONTROL OF PATHOLOGICAL TREMORSAugust 2020July 2021Allow1020NoNo
16991703METHOD AND APPARATUS FOR SUBTRACTION-BASED PROGRAMMING OF NEUROSTIMULATION FIELDSAugust 2020December 2022Allow2910YesNo
16985955PERIPHERAL NERVE FIELD STIMULATION CONTROLAugust 2020April 2023Allow3320YesNo
16942314NEUROSTIMULATION SYSTEM WITH NEURODEGENERATIVE DISEASE DETECTIONJuly 2020October 2022Allow2710YesNo
16955775Nerve StimulatorJuly 2020April 2023Allow3430YesNo
16920010ELECTRICAL NERVE STIMULATORJuly 2020December 2022Allow3020NoNo
16771441NEUROMODULATION OF GANGLIAJune 2020May 2022Allow2320NoNo
16881442SYSTEMS AND METHODS TO PLACE ONE OR MORE LEADS IN TISSUE TO ELECTRICALLY STIMULATE NERVES TO TREAT PAINMay 2020December 2021Allow1910NoNo
16879530TEMPORARY ELECTRODE CONNECTION FOR WIRELESS PACING SYSTEMSMay 2020June 2022Abandon2520YesNo
16860171ELECTRICAL TREATMENT DEVICE, CONTROL METHOD, AND TREATMENT SYSTEMApril 2020August 2023Allow3911NoNo
16851445NECK MASSAGING DEVICEApril 2020April 2022Abandon2410NoNo
16840101DEVICE FOR ELECTROTHERAPY AND/OR ELECTROPHYSIOLOGY, KIT AND ASSEMBLYApril 2020May 2022Allow2510NoNo
16827472Primary Dysmenorrhea Pain ReductionMarch 2020March 2022Abandon2410NoNo
16819382Methods and Apparatus For Electrically Inducing A Peripheral Nerve BlockadeMarch 2020January 2022Allow2210NoNo
16803541Non-Invasive Determination of Disease StatesFebruary 2020June 2022Allow2711NoNo
16801952DEVICES AND METHODS FOR TREATING EDEMAFebruary 2020March 2023Allow3730NoNo
16797115POSTURE-BASED PARESTHESIA THRESHOLD OR PERCEPTION THRESHOLD DETERMINATIONFebruary 2020March 2022Allow2420YesNo
16795822DEVICE AND METHOD TO MODULATE A NERVOUS SYSTEM STRUCTURE TO NON-INVASIVELY AND NON-DESTRUCTIVELY INHIBIT NERVOUS SIGNALINGFebruary 2020April 2022Allow2510NoNo
16787877Method and System for Automated Neuromodulation through Machine LearningFebruary 2020December 2021Abandon2221YesNo
16780036LEAD-IN-LEAD SYSTEMS AND METHODS FOR CARDIAC THERAPYFebruary 2020February 2023Allow3620YesNo
16634620ELECTRODE DEVICES FOR NEUROSTIMULATIONJanuary 2020September 2022Allow3220YesNo
16751614REMOTE PAIN MANAGEMENT THROUGH ELECTRICAL STIMULATION OF MERIDIAN BODY LINESJanuary 2020September 2022Allow3220YesNo
16734575TERMINAL DEVICE, CONTROL METHOD, PROGRAM, AND TREATMENT SYSTEMJanuary 2020December 2021Allow2420YesNo
16722440EXTENDABLE/RETRACTABLE ACTIVE FIXATION CRM LEAD TIP DESIGN FOR TURN COUNT CONSISTENCYDecember 2019March 2023Allow3920YesNo
16711496MODULAR NEUROLOGICAL SCREENING ADAPTER SYSTEM FOR INTRAOPERATIVE TESTING AND PATIENT-WORN TRIALINGDecember 2019October 2022Allow3420NoNo
16705283TERMINAL DEVICE, TREATMENT SYSTEM, AND PROGRAMDecember 2019April 2022Allow2830YesNo
16697267AUTOMATIC SELECTION OF PARAMETERS OF AN EXPOSURE MODE OF AN IMPLANTABLE MEDICAL DEVICENovember 2019June 2022Allow3020NoNo
16689592SYSTEM AND METHOD FOR DELIVERING MODULATED SUB-THRESHOLD THERAPY TO A PATIENTNovember 2019March 2022Abandon2810NoNo
16614397External Trigeminal Nerve Stimulation for the Acute Non-Invasive Treatment of Migraine AttacksNovember 2019April 2022Allow2910NoNo
16667229METHOD FOR RELATIVE LEAD OFFSET DETERMINATIONOctober 2019August 2022Allow3410NoNo
16664051SINUS TREATMENT DEVICE WITH ADAPTIVE CIRCUITOctober 2019June 2021Allow2010YesNo
16661549Leads for Stimulation and Sensing in a Stimulator DeviceOctober 2019June 2023Abandon4420NoNo
16655440SYSTEM AND METHOD FOR CONSERVING POWER IN A MEDICAL DEVICEOctober 2019January 2023Allow3910YesNo
16594621ELECTROSURGICAL DEVICE WITH DISPOSABLE SHAFT HAVING RACK AND PINION DRIVEOctober 2019December 2021Allow2610YesNo
16591241MANAGED PACE RECHARGE IN A MULTIPOINT PACING SYSTEMOctober 2019October 2021Allow2510NoNo
16586250Systems and Methods for the Automated Delivery of Photobiomodulation Therapy to a PatientSeptember 2019July 2020Allow910NoNo
16582844ELECTRODE PAD CARTRIDGE FOR DEFIBRILLATORSSeptember 2019November 2021Allow2620YesNo
16567116SYSTEMS AND METHODS FOR PROVIDING AND COORDINATING VAGUS NERVE STIMULATION WITH AUDIO THERAPYSeptember 2019December 2021Allow2710YesNo
16556634Methods and Apparatuses for Configuring Artificial Retina DevicesAugust 2019May 2022Allow3320NoNo
16554350LOW-FREQUENCY TREATMENT DEVICE, BODY FOR LOW-FREQUENCY TREATMENT DEVICE, AND COMBINATION OF PAD AND HOLDER FOR LOW-FREQUENCY TREATMENT DEVICEAugust 2019April 2022Allow3220YesNo
16553656Method of searching optimal zones for electropulse therapy (variants)August 2019December 2020Abandon1610YesNo
16550561IMPLANTABLE PACING AND DEFIBRILLATION SYSTEM WITH ILLUMINATED GENERATORSAugust 2019July 2020Allow1110NoNo
16549571WATER RESISTANT WEARABLE MEDICAL DEVICEAugust 2019July 2021Allow2210NoNo
16488141SURGICAL IMPLANT SYSTEMAugust 2019January 2023Allow4130NoNo
16543822SYSTEMS AND METHODS FOR DETECTING HEALTH DISORDERSAugust 2019October 2021Allow2610NoNo
16450915NON-INVASIVE NEUROMODULATION (NINM) FOR REHABILITATION OF BRAIN FUNCTIONJune 2019September 2021Allow2710NoNo
16428262ELECTRICAL STIMULATION DEVICEMay 2019May 2021Allow2310NoNo
16422509USING MULTIPLE DIAGNOSTIC PARAMETERS FOR PREDICTING HEART FAILURE EVENTSMay 2019May 2021Allow2420NoNo
16403379SYSTEM AND METHOD FOR MONITORING BIOMETRIC SIGNALSMay 2019September 2021Allow2820YesNo
16382674ELECTROSURGICAL METHODS AND SYSTEMSApril 2019March 2022Allow3520NoNo
16382095METHOD AND SYSTEM TO ACCELERATE CONFIRMATION OF CARDIAC ARRHYTHMIASApril 2019June 2021Allow2600NoNo
16382072METHOD AND DEVICE FOR MONITORING LEFT VENTRICULAR HYPERTROPHY AND CALCULATING DEFIBRILLATION THRESHOLDSApril 2019September 2021Allow2910NoNo
16341087SINGLE USE DETECTOR FOR AN AUTOMATED EXTERNAL DEFIBRILLATOR (AED)April 2019September 2021Allow2911NoNo
16376595Non-Invasive Neuromodulation (NINM) for Rehabilitation of Brain FunctionApril 2019July 2021Allow2810NoNo
16375348Pediatric and Adult DefibrillatorApril 2019December 2021Allow3320NoNo
16375816Electrically Stimulated CBD Infused Anesthetic Patch SystemApril 2019March 2020Allow1120YesNo
16366758PATTERNED PACING TO REDUCE HYPERTENSIONMarch 2019November 2021Allow3220YesNo
16364309DELIVERY DEVICE FOR DELIVERY OF IMPLANTABLE OR INSERTABLE MEDICAL DEVICESMarch 2019August 2021Allow2920YesNo
16353492DEVICES AND METHODS FOR ENDOLUMINAL DELIVERY OF EITHER FLUID OR ENERGY FOR DENERVATIONMarch 2019April 2021Allow2510NoNo
16284080Non-Invasive Handling of Sleep Apnea, Snoring and Emergency SituationsFebruary 2019February 2021Allow2312NoNo
16267215MEDICAL DEVICE WITH LACK-OF-READINESS ALARMFebruary 2019September 2021Allow3120YesNo
16264030SYSTEMS AND METHODS FOR SAFE DELIVERY OF ELECTRICAL STIMULATION THERAPYJanuary 2019September 2021Allow3120NoNo
16259869FLOORMAT PHYSIOLOGICAL SENSORJanuary 2019June 2021Allow2810NoNo
16258214IMPLANTABLE DEVICE FOR PROVIDING ELECTRICAL STIMULATION OF CERVICAL VAGUS NERVES FOR TREATMENT OF CHRONIC CARDIAC DYSFUNCTIONJanuary 2019January 2021Allow2410NoNo
16254115PUMP ARRANGEMENTJanuary 2019July 2021Allow3020YesNo
16251482SYSTEMS AND METHODS TO PLACE ONE OR MORE LEADS IN TISSUE TO ELECTRICALLY STIMULATE NERVES OF PASSAGE TO TREAT PAINJanuary 2019February 2021Allow2510NoNo
16248692Systems and Methods for Providing Cold Laser Therapy to a Patient in a Hands-Free MannerJanuary 2019September 2019Allow810NoNo
16244152SURGICAL INSTRUMENT WITH CONTAINED DUAL HELIX ACTUATOR ASSEMBLYJanuary 2019September 2021Allow3211NoNo
16200222MEDICAL DEVICE WITH MULTIPLE CHANNEL INDEPENDENT RATE CONTROLNovember 2018July 2021Allow3110YesNo
16188383SYSTEMS AND METHODS FOR ESTIMATING TISSUE PARAMETERS USING SURGICAL DEVICESNovember 2018December 2020Allow2510NoNo
16186050AUTOMATIC THERAPY ADJUSTMENTSNovember 2018January 2022Abandon3820YesNo
16170675MEDIATION OF TRAUMATIC BRAIN INJURYOctober 2018March 2021Allow2910YesNo
16152818METHOD AND SYSTEM FOR DETERMINING THE FITNESS INDEX OF A PERSONOctober 2018September 2020Allow2410NoNo
16134783Signaling Error Conditions in an Implantable Medical Device System Using Simple Charging Coil TelemetrySeptember 2018September 2020Allow2410NoNo
16131988SEAMLESSLY EMBEDDED HEART RATE MONITORSeptember 2018March 2022Allow4240YesNo
16126768Methods and Apparatus For Electrically Inducing Net Macro-Current Across Neuronal Cell MembranesSeptember 2018February 2020Allow1711NoNo
16106805SHOCK DETERMINATION BASED ON PRIOR SHOCKSAugust 2018March 2021Allow3120YesNo
16077641METHOD FOR IDENTIFYING OPTIMAL REGIONS FOR CARDIOVERSION THERAPY (VARIANTS)August 2018March 2020Abandon1920YesNo
16042616IMPLANTABLE MEDICAL DEVICE WITH RADIOPAQUE ID TAGJuly 2018January 2021Allow3011NoNo
16071778ELECTRICAL STIMULUS DEVICEJuly 2018January 2020Allow1820NoNo
16037348IMPLANTABLE NERVE ELECTRODE AND METHOD FOR PRODUCING AN IMPLANTABLE NERVE ELECTRODEJuly 2018March 2021Allow3220NoNo
16030791Miniature ECG Data Acquisition DeviceJuly 2018October 2021Allow4030YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner ALTER MORSCHAUSER, ALYSSA MARGO.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
8
Examiner Affirmed
3
(37.5%)
Examiner Reversed
5
(62.5%)
Reversal Percentile
84.9%
Higher than average

What This Means

With a 62.5% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
25
Allowed After Appeal Filing
10
(40.0%)
Not Allowed After Appeal Filing
15
(60.0%)
Filing Benefit Percentile
67.7%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 40.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner ALTER MORSCHAUSER, ALYSSA MARGO - Prosecution Strategy Guide

Executive Summary

Examiner ALTER MORSCHAUSER, ALYSSA MARGO works in Art Unit 3792 and has examined 240 patent applications in our dataset. With an allowance rate of 87.9%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 29 months.

Allowance Patterns

Examiner ALTER MORSCHAUSER, ALYSSA MARGO's allowance rate of 87.9% places them in the 69% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by ALTER MORSCHAUSER, ALYSSA MARGO receive 1.96 office actions before reaching final disposition. This places the examiner in the 45% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by ALTER MORSCHAUSER, ALYSSA MARGO is 29 months. This places the examiner in the 66% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a -2.2% benefit to allowance rate for applications examined by ALTER MORSCHAUSER, ALYSSA MARGO. This interview benefit is in the 9% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 33.5% of applications are subsequently allowed. This success rate is in the 74% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 46.3% of cases where such amendments are filed. This entry rate is in the 71% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 100.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 78% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 70.4% of appeals filed. This is in the 57% percentile among all examiners. Of these withdrawals, 52.6% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 41.0% are granted (fully or in part). This grant rate is in the 30% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 47% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 52% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.